Pharmaceuticals

Expanded access is supporting growth in the Elonva Market 2026

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Elonva Market From 2026 To 2030?

Historical growth can be ascribed to several contributing factors, such as the rising incidence of infertility, the demonstrated clinical effectiveness of assisted reproduction techniques, the proliferation of fertility clinics, the implementation of hormonal stimulation treatments, and enhanced knowledge of reproductive health.

The expansion projected for the forecast period is fueled by several factors, including the increasing trend of delayed parenthood, a surge in the demand for IVF cycles, continuous technological advancements in fertility medications, enhanced access to healthcare in developing economies, and the broadening of advantageous reimbursement policies.

Significant developments anticipated during this forecast period involve the widespread adoption of single-injection ovarian stimulation protocols, an increase in the volume of IVF procedures, a noticeable shift towards fertility treatments that prioritize patient comfort, improved outcomes for controlled ovarian response, and the growing prevalence of long-acting gonadotropins.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20050&type=smp

What Major Drivers Are Influencing Demand In The Elonva Market?

The increasing incidence of ovarian conditions is anticipated to fuel the expansion of the elonva market in the future. These disorders stem from several causes, such as hormonal irregularities, genetic alterations (like BRCA1 and BRCA2), polycystic ovary syndrome (PCOS), autoimmune diseases, exposure to environmental pollutants, and lifestyle habits including obesity and tobacco use. Elonva aids in managing ovarian disorders by encouraging the ovaries to develop multiple follicles, thereby increasing the likelihood of conception for women facing fertility challenges like polycystic ovary syndrome (PCOS) or unknown infertility. For example, in 2024, the American Cancer Society, a US-based non-profit organization dedicated to cancer advocacy, reported 19,680 new ovarian cancer diagnoses in the US, with 12,740 women succumbing to the illness. Consequently, the growing occurrence of ovarian conditions is propelling the development of the elonva market.

Which Segments Are Included In The Analysis Of The Elonva Market?

The elonva market covered in this report is segmented –

1) By Clinical Indication: In Vitro Fertilization (IVF), Hypogonadotropic Hypogonadism in Adolescent Males, Ovarian Hyperstimulation Syndrome (OHSS) Management

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Fertility Clinics, Hospitals, Research Institutes, Other End Users

Which Trends Are Impacting The Growth Of The Elonva Market?

A primary development within the elonva market centers on securing approvals to broaden the treatment’s availability for patients with platinum-resistant ovarian cancer. This effort aims to address the demand for advanced, targeted therapies for individuals facing this challenging and frequently treatment-resistant form of ovarian cancer. For example, in January 2023, Merck & Co., Inc., a US-based pharmaceutical company, obtained European Commission approval for Elonva, indicated for controlled ovarian stimulation (COS) in women undergoing assisted reproductive technology (ART). This approval facilitates unified labeling across all European Union member states, thereby simplifying access for healthcare providers and patients. Elonva is distinguished by its capacity to replace the initial seven daily injections of conventional follicle-stimulating hormone (FSH) with a single subcutaneous injection, significantly reducing the treatment burden for women endeavoring to conceive.

Which Key Industry Participants Are Active In The Elonva Market?

Major companies operating in the elonva market are Merck & Co. Inc.

Read the full elonva market report here:

https://www.thebusinessresearchcompany.com/report/elonva-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Elonva Market?

North America was the largest region in the elonva market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the elonva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Elonva Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20050&type=smp

Browse Through More Reports Similar to the Global Elonva Market 2026, By The Business Research Company

Esg Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/esg-finance-global-market-report

Luxury Resale Market Report 2026

https://www.thebusinessresearchcompany.com/report/luxury-resale-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795